Precipio, Inc - PRPO Net earnings per share (EPS TTM)

Precipio Inc. (PRPO) - corporate logo

Precipio, Inc. (PRPO) is optimizing the delivery of oncology samples to preserve profits by transitioning to licensed software for liquid biopsy. This chart on GURU.Markets reveals a yearly shift in EPS TTM, where the 23.00 metric indicates the status of current profit dynamics. Precipio, Inc. (PRPO) is implementing a platform for tumor genetics analysis, providing physicians with the ability to select personalized therapies for effective treatment.

Precipio, Inc (PRPO) - Net earnings per share for the last 12 months from 02/11/2024 to 11/14/2026

Precipio, Inc - analytical breakdowns and key metrics (PRPO)

- share price and consensus valuation forecast:
Share Price precipiodx.com|PRPO - Analyst Consensus Forecast
- issuer market value details:
Market Capitalization Precipio Inc.|PRPO - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Precipio|PRPO - Company Net Assets|Market-to-Book Ratio precipiodx.com|PRPO - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Precipio, Inc.|PRPO - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Precipio Inc|PRPO - Company Debts|Debts to Net Assets Precipio Inc.|PRPO - Company Long-Term Debt|Current Liabilities Precipio|Intermediate Coverage Ratio precipiodx.com
- earnings and valuation multiples indicators:
PRPO - Net Profit|Expected Net Profit Precipio, Inc.|PRPO - P/E Multiple|Projected Price to Earnings Precipio Inc.|PRPO - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Precipio Inc.|PRPO - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Precipio|PRPO - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months precipiodx.com|PRPO - Earnings per share growth in current year|Expected net earnings per share growth next year Precipio, Inc.
- sales volume and revenue information:
PRPO - Company Sales|Company Future Revenue precipiodx.com|PRPO - P/S Multiple|Market Cap to Expected Sales Ratio Precipio Inc.
Initial company analysis:PRPO (precipiodx.com)
Original product of Precipio, Inc.

The analysis of Precipio, Inc. (PRPO) business resilience to market volatility is based on the diversification of revenues from oncology diagnostics and reagent supplies, which create a stable cash flow. Comparable annual EPS TTM growth measures the net profit per share dynamics over twelve months, allowing investors to assess the actual efficiency of profit capitalization and avoid purchasing the asset at the peak of inflated expectations.

Competitor analysis

CAI (carislifesciences.com) - Earnings per share for the last 12 months|GH: Net earnings per share (EPS TTM)|Veracyte Inc (VCYT) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Celcuity Corp|Earnings per share for the last twelve months GRAL|Net earnings per share for the last 12 months MYGN (Myriad Genetics, Inc.)|CSTL - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Burning Rock BNR|Net earnings per share for the last four quarters VolitionRx Ltd. (VNRX)|Biodesix Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Check-Cap Ltd. CHEK|Mainz Biomed N.V. (MYNZ) - Earnings per share for the last twelve months|OCX - Net earnings per share for the last four quarters